Home monitoring in Idiopathic Pulmonary Fibrosis: improving use of anti-fibrotic medication and quality of life

C.C. Moor
This was a multicenter randomised controlled trial on the effects of a home monitoring program on quality of life and medication use in patients with idiopathic pulmonary fibrosis. Patients were randomized (1:1) to standard care alone or a home monitoring program on top of standard care for 24 weeks. The primary outcome was between-group change in score of the validated K-BILD questionnaire. This dataset contains the metadata of the study.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.